Cislini Jeff's Form 4 filing
Revolution Medicines, Inc. (RVMD) · filed Sep 18, 2026
- Accession no.
- 0001969082-26-000009
- Filed
- Sep 18, 2026, 6:01 PM ET
- Trade date
- Sep 16, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $670.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cislini JeffCIK 0001969082 | Officer (SVP & General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Common Stock | SSaleDisposed | −52 | $195.01 | −$10,140.45 | 55,855 | Direct | |
| Sep 16, 2026 | Common Stock | SSaleDisposed | −3,314 | $199.30 | −$660,490.8 | 52,541 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.